INNATE PHARMA SA (IPHA): Price and Financial Metrics

INNATE PHARMA SA (IPHA): $1.69

0.20 (+13.12%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add IPHA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#103 of 471

in industry

IPHA Price/Volume Stats

Current price $1.69 52-week high $3.15
Prev. close $1.49 52-week low $1.29
Day low $1.60 Volume 7,600
Day high $1.70 Avg. volume 9,221
50-day MA $1.99 Dividend yield N/A
200-day MA $2.31 Market Cap 136.47M

IPHA Stock Price Chart Interactive Chart >


INNATE PHARMA SA (IPHA) Company Bio


Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells.


IPHA Latest News Stream


Event/Time News Detail
Loading, please wait...

IPHA Latest Social Stream


Loading social stream, please wait...

View Full IPHA Social Stream

IPHA Price Returns

1-mo -11.75%
3-mo -23.53%
6-mo -41.75%
1-year -28.99%
3-year -64.86%
5-year -71.64%
YTD -39.64%
2023 -24.93%
2022 -18.20%
2021 11.49%
2020 -36.49%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!